About Olivia
Dr Olivia Cavlan, MBChB is a biotech builder and former clinician scientist. She has been a member of the Cancer Research Horizons Seed Fund Investment Committee since 2019.
Olivia was a founding team member and Chief Corporate Development and Strategy Officer at Alchemab Therapeutics. She co-founded and sits on the board of directors of Sevenless Therapeutics, is a non-executive director for the UK BioIndustry Association and is also a Partner at LifeArc Ventures.
Previously, Olivia was an investment principal at SV Health Investors and a partner with McKinsey & Company where she was part of the leadership team in the Healthcare Private Equity and Pharmaceutical practices.